Gemcitabine and Carboplatin in Intensively Pretreated Patients with Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|73|5-6|407-414

ISSN： 0030-2414

Source： Oncology, Vol.73, Iss.5-6, 2008-06, pp. : 407-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Salvage Chemotherapy with Gemcitabine and Oxaliplatin in Heavily Pretreated Patients with Metastatic Breast Cancer: A Multicenter Phase II Study

By  

Oncology, Vol. 70, Iss. 4, 2006-10 ,pp. : 273-279

Karger

Access to resources Recommend Favorite

Treatment Options in Anthracycline and/or Taxane Pretreated Patients with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 476-478

Karger

Access to resources Recommend Favorite

Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology Group

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

A Multicenter Phase II Study of Docetaxel in Combination with Gefitinib in Gemcitabine-Pretreated Patients with Advanced/Metastatic Pancreatic Cancer

By  

Oncology, Vol. 71, Iss. 3-4, 2007-07 ,pp. : 159-163

Karger

Access to resources Recommend Favorite

Phase I Study of Vinorelbine and Carboplatin Combination in Patients with Taxane and Anthracycline Pretreated Advanced Breast Cancer

By  

Oncology, Vol. 62, Iss. 2, 2002-03 ,pp. : 103-109

Karger

Access to resources Recommend Favorite